GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $862,000 | -0.1% | 19,825 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $863,000 | -1.5% | 19,825 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $876,000 | +32.9% | 19,870 | +15.1% | 0.00% | +50.0% |
| Q3 2021 | $659,000 | -7.7% | 17,270 | -3.8% | 0.00% | -33.3% |
| Q2 2021 | $714,000 | +7.4% | 17,950 | -3.8% | 0.00% | 0.0% |
| Q1 2021 | $665,000 | -7.9% | 18,651 | -4.9% | 0.00% | 0.0% |
| Q4 2020 | $722,000 | -11.3% | 19,621 | -9.4% | 0.00% | -25.0% |
| Q3 2020 | $814,000 | -10.8% | 21,645 | -3.4% | 0.00% | -20.0% |
| Q2 2020 | $913,000 | +7.2% | 22,406 | -0.4% | 0.01% | -16.7% |
| Q1 2020 | $852,000 | -13.7% | 22,486 | +7.0% | 0.01% | +20.0% |
| Q4 2019 | $987,000 | -29.6% | 21,011 | -36.0% | 0.01% | -37.5% |
| Q3 2019 | $1,402,000 | +1.8% | 32,850 | -4.6% | 0.01% | 0.0% |
| Q2 2019 | $1,377,000 | -5.9% | 34,425 | -1.7% | 0.01% | 0.0% |
| Q1 2019 | $1,463,000 | +9.8% | 35,018 | +0.4% | 0.01% | 0.0% |
| Q4 2018 | $1,332,000 | +3.4% | 34,879 | +8.7% | 0.01% | +14.3% |
| Q3 2018 | $1,288,000 | +34.6% | 32,079 | +35.0% | 0.01% | +16.7% |
| Q2 2018 | $957,000 | +3.1% | 23,759 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $928,000 | +3.3% | 23,759 | -6.2% | 0.01% | 0.0% |
| Q4 2017 | $898,000 | -15.6% | 25,323 | -3.4% | 0.01% | -16.7% |
| Q3 2017 | $1,064,000 | -14.1% | 26,208 | -8.7% | 0.01% | -14.3% |
| Q2 2017 | $1,238,000 | -19.9% | 28,720 | -21.7% | 0.01% | -22.2% |
| Q1 2017 | $1,546,000 | +8.5% | 36,686 | -0.9% | 0.01% | 0.0% |
| Q4 2016 | $1,425,000 | -24.0% | 37,013 | -14.8% | 0.01% | -18.2% |
| Q3 2016 | $1,874,000 | -4.7% | 43,465 | -4.2% | 0.01% | -8.3% |
| Q2 2016 | $1,967,000 | +10.8% | 45,391 | +3.6% | 0.01% | +9.1% |
| Q1 2016 | $1,776,000 | -66.7% | 43,806 | -66.9% | 0.01% | -66.7% |
| Q4 2015 | $5,337,000 | -0.1% | 132,279 | -4.8% | 0.03% | -2.9% |
| Q3 2015 | $5,344,000 | -20.5% | 138,999 | -13.9% | 0.03% | -15.0% |
| Q2 2015 | $6,725,000 | -16.9% | 161,480 | -8.0% | 0.04% | -14.9% |
| Q1 2015 | $8,096,000 | -3.1% | 175,444 | -10.3% | 0.05% | 0.0% |
| Q4 2014 | $8,356,000 | -77.4% | 195,519 | -75.7% | 0.05% | -78.1% |
| Q3 2014 | $36,964,000 | -53.9% | 804,105 | -46.4% | 0.22% | -57.8% |
| Q2 2014 | $80,264,000 | -1.9% | 1,500,833 | -2.0% | 0.51% | -5.6% |
| Q1 2014 | $81,823,000 | -4.5% | 1,531,412 | -4.6% | 0.54% | -4.8% |
| Q4 2013 | $85,685,000 | +5.7% | 1,604,890 | -0.7% | 0.57% | 0.0% |
| Q3 2013 | $81,087,000 | -3.3% | 1,616,253 | -1.4% | 0.57% | -1.9% |
| Q2 2013 | $83,816,000 | – | 1,638,958 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |